4
Changes in Ownership
CYTOKINETICS INC Filed Acc 0001127602-24-014445
EVP Research & Development sold 15,547 shares at $65.11 ($1,012,265)
- EVP Research & Development acquired 14,186 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Malik Fady Ibraham · EVP Research & Development
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-07 | Exercise or conversion : show line 1 in the form 10b5-1 | +14,186 | $6.67 | $94,621 | 152,603 | D |
| 2024-05-07 | Sale : show line 2 in the form 10b5-1 | −14,186 | $65.11 | $923,650 | 138,417 | D |
| 2024-05-07 | Sale : show line 3 in the form 10b5-1 | −1,361 | $65.11 | $88,615 | 137,056 | D |
| Open-market sales · 15,547 sh · avg $65.11 · $1,012,265 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-05-07 | Exercise or conversion : show line 4 in the form 10b5-1 Incentive Stock Option (Right to Buy) | −14,186 | 0 | D |
Loading xslF345X05/form4.xml…